Scopio Labs Receives FDA Clearance for Decision Support System on X100 and X100HT Platforms
Scopio Labs has received its fourth FDA clearance for enhanced decision support features in its X100 and X100HT platforms.
Scopio Labs has received its fourth FDA clearance for enhanced decision support features in its X100 and X100HT platforms.
The launch focuses on several immunooncology markers that are critical for early-stage cancer drug development and patient treatment.
Opal research kits with rapid multiplexing capabilities are now available for the LabSat Research tissue staining platform.
Offering unambiguous identification and storage of fresh frozen tissue samples, the tubes have a 2D data-matrix code laser-encrypted on the tube bottom and a large readable code on the tube sidewall.
Read MoreThe assay is intended for laboratory use to detect the anaplastic lymphoma kinase protein in formalin-fixed, paraffin-embedded, non-small cell lung carcinoma tissue stained using the Ventana BenchMark XT or Ventana BenchMark Ultra automated immunohistochemical slide strainers.
Read MoreDefiniens has partnered with Indivumed to offer a combination of tissue-based biomarker validation and assay development, using the Definiens Cognition Network technology for image analysis and data mining.
Read MoreThis month’s issue features anatomic and digital pathology technologies from such companies as Aspyra, Leica Biosystems, Mikroscan Technologies, and Philips.
Read MoreAn updated software package from Definiens seeks to detect regions of interest accurately and distinguish cell types and cell subtypes within target regions across any number of tissue slides.
Read MoreIn partnership with biopharmaceutical companies, Leica Biosystems and Advanced Cell Diagnostics are collaborating to develop and commercialize fully automated RNAscope-based companion diagnostics.
Read MoreThe fully automated hematoxylin and eosin tissue staining system eliminates the use of xylene and alcohol, reducing technician exposure to harmful chemicals.
Read MoreThe assay enables rapid assessment of tissue-based biomarker expression across the full spectrum of clinical formalin-fixed, paraffin-embedded tissue samples without the need for lengthy rounds of assay optimization.
Read MoreThis issue’s Product Spotlight features anatomic and digital technologies from companies such as Psyche Systems, Technidata, and Viewics.
Read MoreNoninvasive liquid biopsy enables detection of emerging T790M mutations with greater sensitivity than tissue biopsy and months before detection of cancer progression with imaging.
Read MoreThe ATUMtome, an automated tape-collecting ultramicrotome from RMC Products and Zeiss, uses an innovative tape collecting method that facilitates the efficient sectioning and handling of large volumes of biological samples for 3-D image reconstruction.
Read MoreThe International Symposium for Tissue Phenomics will feature thought leaders on companion diagnostics, immunotherapy, and tissue-based patient stratification for personalized medicine.
Read MoreAcroMetrix MultiMix FFPE Controls from Life Technologies, Carlsbad, Calif, are process controls for the isolation, purification, and detection of somatic genetic variants in research oncology testing.
Read MoreThe Siemens Tissue Preparation Solution allows molecular pathology laboratories to integrate samples from both fresh frozen and formalin-fixed, paraffin-embedded tissues into the same workflow, automating the standardized isolation of nucleic acids.
Read MoreAutomated for use on the VENTANA BenchMark Special Stains instrument, the Gram Staining Kit aids pathologists in the most basic classification of bacteria into Gram-positive and Gram-negative bacteria in fixed tissue samples.
Read More